Accepted
at 12:47 a.m. May, 09, 2025
by
marcoszan
Author:
andrecunha
Type of change:
Updated content
Rationale for change
A resposta afirma que mulheres vivendo com HIV podem usar "todos os métodos anticoncepcionais", mas logo abaixo já são descritas contraindicações: imunossupressão avançada (CD4 < 200), infecção genital/pélvica ativa e TARV. isso DEFINITIVAMENTE pode confundir.
Sugiro reformulção do card e adição das contraindicações relativas no mesmo card ou em um outro
Before
After
Front
Front
Back
Back
Importante
Importante
Front
Front
Back
Back
Importante
Importante
Anotação
Empty field
Observação
Empty field
Apresentação
Empty field
Fisiopatologia
Empty field
Clínica
Empty field
Diagnóstico
Empty field
Conduta
Empty field
Galeria
Empty field
Referência
- World Health Organization. Contraceptive eligibility for women at high risk of HIV. https://www.who.int/reproductivehealth/publications/contraceptive-eligibility-women-at-high-risk-of-HIV/en/ (Accessed on September 03, 2019).
- Polis CB, Phillips SJ, Curtis KM, et al. Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence. Contraception 2014; 90:360.
- Ralph LJ, McCoy SI, Shiu K, Padian NS. Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies. Lancet Infect Dis 2015; 15:181.
- Polis CB, Curtis KM, Hannaford PC, et al. An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women. AIDS 2016; 30:2665.
- Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial. Lancet 2019; 394:303.
Banca
Empty field
One by one
Empty field
©Ankiclass
Empty field